Skip to content

The Lancet Regional Health—Europe News

Share

Stopping GLP-1 Drugs Linked to Higher Cardiovascular Risk in Type 2 Diabetes

GLP-1 drugs: Stopping doubles heart attack, stroke or death risk

GET IT ONGoogle Play

© 2026 Cupure — News in seven languages. Read it, discuss it.

en de fr it es tr nl

News map Videos What is Cupure Editorial Standards Contact Terms of Use Privacy Account Deletion

Designed by Monolic